Physicians' Academy for Cardiovascular Education

Risks associated with hyperkalemia

10' education - Sep. 16, 2021 - Prof. Stefan Anker, MD, PhD - Berlin, Germany

Video navigation menu

  • Definition of hyperkalemia 01:03
  • Major causes of hyperkalemia 02:44
  • Problems and risks associated with hyperkalemia 04:10
  • Hyperkalemia is associated with submaximal dose or discontinuation of RAASi 05:50

Educational information

This lecture by Stefan Anker was part of an accredited symposium "Potassium binding in heart failure management - Enabling guideline-recommended RAASi therapy" held during the virtual ESC Congress 2021.

Faculty

Prof. Stefan Anker, MD, PhD is Head of Field “Tissue Homeostasis and Cachexia" at Charité University, Berlin, Germany.

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Funding

Funding for this educational program was provided by an unrestricted educational grant received from Vifor Pharma.

Click here for the meeting report View slides of this presentation

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: